NYSE:MET - Metlife Stock Price, Price Target & More

Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

Metlife announced a quarterly dividend on Friday, July 6th. Shareholders of record on Monday, August 6th will be paid a dividend of $0.42 per share on Thursday, September 13th. This represents a $1.68 dividend on an annualized basis and a yield of 3.78%. The ex-dividend date of this dividend is Friday, August 3rd. View Metlife's Dividend History.

Metlife announced that its Board of Directors has initiated a stock repurchase plan on Tuesday, May 22nd 2018, which authorizes the company to buyback $1,500,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to purchase up to 3.1% of its shares through open market purchases. Shares buyback plans are generally a sign that the company's board of directors believes its shares are undervalued.

Metlife Inc (NYSE:MET) announced its quarterly earnings results on Wednesday, May, 2nd. The financial services provider reported $1.36 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.17 by $0.19. The financial services provider earned $15.15 billion during the quarter, compared to analyst estimates of $15.52 billion. Metlife had a return on equity of 8.70% and a net margin of 6.48%. The company's revenue was up .6% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.20 earnings per share. View Metlife's Earnings History.

17 analysts have issued 1 year price targets for Metlife's stock. Their forecasts range from $47.00 to $78.00. On average, they anticipate Metlife's share price to reach $56.60 in the next twelve months. This suggests a possible upside of 27.4% from the stock's current price. View Analyst Ratings for Metlife.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 9 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Metlife saw a drop in short interest in June. As of June 29th, there was short interest totalling 12,020,672 shares, a drop of 28.9% from the June 15th total of 16,900,543 shares. Based on an average daily trading volume, of 7,086,353 shares, the short-interest ratio is presently 1.7 days. Approximately 1.4% of the shares of the stock are short sold. View Metlife's Current Options Chain.

Some companies that are related to Metlife include China Life Insurance (LFC), Prudential Public (PUK), AXA (AXAHY), Prudential Financial (PRU), Manulife Financial (MFC), SWISS RE Ltd/S (SSREY), AVIVA PLC/ADR (AVVIY), Sun Life Financial (SLF), HANNOVER RUECK/S (HVRRY), Legal & General Group (LGEN), AMP (AMP), Lincoln National (LNC), OLD Mut PLC/ADR (ODMTY), AEGON (AEG) and Torchmark (TMK).

Press coverage about MET stock has trended somewhat positive this week, Accern reports. The research firm identifies positive and negative news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Metlife earned a news sentiment score of 0.15 on Accern's scale. They also gave news coverage about the financial services provider an impact score of 46.05 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

Metlife's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BOARD OF DIRECTORS OF METLIFE INC (15.00%), Bank of Montreal Can (0.19%), NN Investment Partners Holdings N.V. (0.17%), Lodestar Investment Counsel LLC IL (0.04%), Gofen & Glossberg LLC IL (0.03%) and Fjarde AP Fonden Fourth Swedish National Pension Fund (0.02%). Company insiders that own Metlife stock include Christopher G Townsend, Frans Hijkoop, Gerald L Hassell, James M Kilts, Maria R Morris and Peter M Carlson. View Institutional Ownership Trends for Metlife.

MET stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Welch & Forbes LLC, Gofen & Glossberg LLC IL, Gateway Investment Advisers LLC, Cullinan Associates Inc., Franklin Street Advisors Inc. NC, Fjarde AP Fonden Fourth Swedish National Pension Fund and CENTRAL TRUST Co. View Insider Buying and Selling for Metlife.

MET stock was purchased by a variety of institutional investors in the last quarter, including Howard Capital Management Inc., Capital One National Association, Farmers Trust Co., DAVENPORT & Co LLC, NN Investment Partners Holdings N.V., Addenda Capital Inc., State of Alaska Department of Revenue and IFM Investors Pty Ltd. Company insiders that have bought Metlife stock in the last two years include Gerald L Hassell and James M Kilts. View Insider Buying and Selling for Metlife.

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MET stock can currently be purchased for approximately $44.44.

Metlife has a market capitalization of $44.93 billion and generates $62.09 billion in revenue each year. The financial services provider earns $4.01 billion in net income (profit) each year or $4.50 on an earnings per share basis. Metlife employs 49,000 workers across the globe.

Metlife's mailing address is 200 Park Avenue, New York NY, 10166. The financial services provider can be reached via phone at 212-578-9500.